(Q43850371)

27 November 2017

title

A sensitive antiviral neutralization bioassay for measuring antibodies to interferons (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

30 October 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

30 October 2022

M. B. Hansen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1690246

30 October 2022

C. Ross

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1690246

30 October 2022

K. Berg

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1690246

30 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1690246

30 October 2022

publication date

1 March 1990

1 reference

27 November 2017

9 March 1990

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1690246

full work available at URL

30 October 2022

https://api.elsevier.com/content/article/PII:0022175990900746?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

https://api.elsevier.com/content/article/PII:0022175990900746?httpAccept=text/plain

30 October 2022

1 reference

Crossref

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

Journal of Immunological Methods

30 October 2022

published in

1 reference

27 November 2017

volume

127

1 reference

27 November 2017

1 reference

27 November 2017

page(s)

241-248

1 reference

Identification, production, and characterization of murine monoclonal antibody (LO-22) recognizing 12 native species of human alpha interferon.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

Anti-interferon antibodies: a perspective

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

The detection of antibodies to recombinant interferon alfa-2a in human serum

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

Quantitation of neutralization of interferon by antibody

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

A radioimmunologic technique to screen for antibodies to α-2 interferon

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90074-6

30 October 2022

Identifiers

1 reference

27 November 2017

1 reference